Godavari Drugs Ltd

Godavari Drugs FY26: Revenue & PAT dip, but net worth jumps to ₹7,579.89 Lakhs; anti-HIV plant in trials 🏭

- Revenue from operations: ₹10,580.81 Lakhs (prev yr ₹11,335.01 Lakhs)

- PAT: ₹408.91 Lakhs (prev yr ₹438.00 Lakhs)

- EPS (basic): ₹5.43 (prev yr ₹5.82)

- PAT margin: 3.87; EBIDTA margin: 10.51

- Net worth: ₹7,579.89 Lakhs (prev yr ₹4,334.61 Lakhs)

- Cash & cash equivalents: ₹1,450.94 Lakhs (prev yr ₹237.33 Lakhs)

- Total assets: ₹20,043.13 Lakhs (prev yr ₹14,307.64 Lakhs)

- Anti-HIV intermediates facility under production trials & stabilization

- Proposed alteration of Main Objects to include nutraceuticals, natural extracts

- Allotted 23,60,065 Fully Convertible Warrants to Promoter group at ₹89 each